FDA.reportPublic FDA data

Multrys trace elements 4 in 1 ml Injection

RxCUI
2568579
RxNorm name
Multrys trace elements 4 in 1 ml Injection
Display name
Multrys trace elements 4 in 1 ml Injection
Full name
Multrys trace elements 4 in 1 ml Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:09

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MultrysTRACE ELEMENTS INJECTION 4American Regent, Inc.995f1efa-aca0-4b6c-9099-f8e757c2133a2024-07-01Warnings, Adverse reactionsExact identifier
rxcui: 2568579

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
995f1efa-aca0-4b6c-9099-f8e757c2133aMultrys trace elements 4 in 1 ml Injection [PSN] · 1 ML copper sulfate 0.15 MG/ML / manganese sulfate 0.00822 MG/ML / selenious acid 0.0098 MG/ML / zinc sulfate 2.47 MG/ML Injection [Multrys] [SBD] · 1 ML copper sulfate 0.15 MG/ML / manganese sulfate 0.00822 MG/ML / selenious acid 0.0098 MG/ML / ZnSO4 2.47 MG/ML Injection [Multrys] [SY] · Multrys (copper sulfate 150 MCG (copper 60 MCG) / manganese sulfate 8.22 MCG (manganese 3 MCG) / selenious acid 9.8 MCG (selenium 6 MCG) / zinc sulfate 2470 MCG (zinc 1000 MCG)) per 1 ml Injection [SY]44These highlights do not include all the information needed to use MULTRYS ® safely and effectively. See full prescribing information for MULTRYS ® . MULTRYS ® (trace elements injection 4* ) for intravenous use Initial U.S. Approval: 202020240701